Stocks TelegraphStocks Telegraph
Stock Ideas

IVVD Company Profile and Key Details

NASDAQ : IVVD

Invivyd, Inc.

$1.61
0.23+16.67%
Open: 4:00 PM
67.76
ESG ScoreESG Rating

IVVD Stock Price Chart

Stock Price Today

Invivyd, Inc. (IVVD) stock surged +16.67%, trading at $1.61 on NASDAQ, up from the previous close of $1.38. The stock opened at $1.34, fluctuating between $1.34 and $1.62 in the recent session.

Stock Snapshot

1.38
Prev. Close
1.34
Open
192.58M
Market Cap
119.62M
Number of Shares
1.34
Day Low
1.62
Day High
-0.83
P/E Ratio
50.57%
Free Float in %
-1.95
EPS (TTM)
1.62
Book Value
-1.58
Cash Flow per Share
7.24M
Volume

Stock Price History Chart

DateOpenHighLowCloseVolume
Feb 14, 20251.341.621.341.617.07M
Feb 13, 20251.411.471.301.384.63M
Feb 12, 20251.551.671.421.524.95M
Feb 11, 20251.411.771.261.6811.35M
Feb 10, 20252.042.051.431.5718.51M
Feb 07, 20252.002.641.962.0427.46M
Feb 06, 20252.522.741.881.9873.67M
Feb 05, 20251.172.340.982.1179.18M
Feb 04, 20251.261.431.041.2595.94M
Feb 03, 20250.441.110.441.06448.53M
Jan 31, 20250.400.400.360.361.65M
Jan 30, 20250.380.400.350.39649K
Jan 29, 20250.420.420.380.391.29M
Jan 28, 20250.420.430.410.41481.8K
Jan 27, 20250.460.500.410.411.33M
Jan 24, 20250.440.480.430.471.06M
Jan 23, 20250.410.440.410.42843.5K
Jan 22, 20250.400.420.390.41397.73K
Jan 21, 20250.410.430.380.41511.8K
Jan 17, 20250.440.450.400.41760.5K

Contact Details

Waltham, MA 02451

United States

Website: https://adagiotx.comContact: 781 819 0080

About Company

Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatment and prevention of coronavirus disease. Adagio Therapeutics, Inc. has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies; and the Scripps Research Institute to perform research activities to identify vaccine candidates for the prevention, diagnosis or treatment of influenza or beta coronaviruses. The company was incorporated in 2020 and is based in Waltham, Massachusetts.

Company Information

Employees94
Beta0.66
Sales or Revenue$0.00
5Y Sales Change%0%
Fiscal Year EndsDecember
SectorHealthcare
IndustryBiotechnology

Frequently Asked Questions

What is the current Invivyd, Inc. (IVVD) stock price?

Invivyd, Inc. (NASDAQ: IVVD) stock price is $1.61 in the last trading session. During the trading session, IVVD stock reached the peak price of $1.62 while $1.34 was the lowest point it dropped to. The percentage change in IVVD stock occurred in the recent session was 16.67% while the dollar amount for the price change in IVVD stock was $0.23.

IVVD's industry and sector of operation?

The NASDAQ listed IVVD is part of Biotechnology industry that operates in the broader Healthcare sector. Invivyd, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of IVVD?

Ms. Laura Walker Ph.D.
Co-Founder & Chief Scientific Officer
Ms. Jill Andersen J.D.
Chief Legal Officer & Corporation Sec.
Mr. David Hering M.B.A.
Chief Executive Officer & Director
Ms. Kyra Rosow Faircloth M.S.
Vice President of Gov. Affairs, Advocacy & Corporation Communication
Ms. Stacy Price
Chief Technology & Manufacturing Officer
Dr. Elham Hershberger Pharm.D.
Chief Devel. Officer
Mr. Jeremy Gowler
Chief Operating Officer & Chief Commercial Officer
Kyra Rosow Faircloth
Vice President of Gov. Affairs, Advocacy & Corporation Communication
Dr. Rebecca Dabora Ph.D.
Chief Technology & Manufacturing Officer
Ms. Stacy Price M.S.
Chief Technology & Manufacturing Officer
Dr. Peter Schmidt M.D.
Chief Medical Officer
Dr. Peter C. Schmidt M.D., M.S., M.Sc.
Chief Medical Officer
Ms. Heidi Spurling M.S.
Vice President of Strategy & Operations and Chief of Staff to the Chief Executive Officer
Dr. Peter C. Schmidt M.D., M.Sc.
Chief Medical Officer
Ms. Kyra Rosow Faircloth
Vice President of Gov. Affairs, Advocacy & Corporation Communication
Ms. Julie Green M.B.A.
Senior Vice President of HR
Lukas Dillinger Ph.D.
Interim Head of Discovery & Pre-Clinical
Mr. Frederick W. Driscoll
Interim Chief Financial Officer, Principal Financial Officer & Principal Accounting Officer
Ms. Heidi Spurling
Vice President of Strategy & Operations and Chief of Staff to the Chief Executive Officer
Dr. Robert D. Allen Ph.D.
Chief Scientific Officer

How IVVD did perform over past 52-week?

IVVD's closing price is 353.52% higher than its 52-week low of $0.36 where as its distance from 52-week high of $4.74 is -66.03%.

How many employees does IVVD have?

Number of IVVD employees currently stands at 94.

Link for IVVD official website?

Official Website of IVVD is: https://adagiotx.com

How do I contact IVVD?

IVVD could be contacted at phone 781 819 0080 and can also be accessed through its website. IVVD operates from 1601 Trapelo Road, Waltham, MA 02451, United States.

How many shares of IVVD are traded daily?

IVVD stock volume for the day was 7.24M shares. The average number of IVVD shares traded daily for last 3 months was 13.86M.

What is the market cap of IVVD currently?

The market value of IVVD currently stands at $192.58M with its latest stock price at $1.61 and 119.62M of its shares outstanding.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph